Pankaj Mohan
2016 - Outlook Therapeutics
In 2016, Pankaj Mohan earned a total compensation of $13.2M as Chairman, President and Chief Executive Officer at Outlook Therapeutics, a 4,019% increase compared to previous year.
Compensation breakdown
| Bonus | $990,000 |
|---|---|
| Salary | $369,926 |
| Stock Awards | $11,787,997 |
| Other | $26,658 |
| Total | $13,174,581 |
Mohan received $11.8M in stock awards, accounting for 89% of the total pay in 2016.
Mohan also received $990K in bonus, $369.9K in salary and $26.7K in other compensation.
Rankings
In 2016, Pankaj Mohan's compensation ranked 302nd out of 14,075 executives tracked by ExecPay. In other words, Mohan earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 302 out of 14,075 | 98th |
Division Manufacturing | 94 out of 5,489 | 98th |
Major group Chemicals And Allied Products | 26 out of 1,895 | 99th |
Industry group Drugs | 21 out of 1,538 | 99th |
Industry Biological Products, Except Diagnostic Substances | 4 out of 279 | 99th |
Source: SEC filing on September 29, 2017.
Mohan's colleagues
We found three more compensation records of executives who worked with Pankaj Mohan at Outlook Therapeutics in 2016.
News
Chanticleer Holdings CEO Pankaj Mohan's 2023 pay rises 2% to $1M
August 19, 2024
Chanticleer Holdings CEO Pankaj Mohan's 2022 pay jumps 27% to $1M
August 7, 2023
Chanticleer Holdings CEO Pankaj Mohan's 2021 pay falls 58% to $792K
April 11, 2022
Outlook Therapeutics CEO Pankaj Mohan's 2018 pay rises 14% to $1.2M
August 1, 2019